We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 41-60 of 10,000 results
  1. The relationship between low prolactin and type 2 diabetes

    Prolactin (PRL) is secreted throughout life in men and women. At elevated levels, its physiological role in pregnancy and lactation, and pathological...

    Gie Ken-Dror, David Fluck, ... Thang Sieu Han in Reviews in Endocrine and Metabolic Disorders
    Article Open access 18 May 2024
  2. Weight loss to disrupt type 2 diabetes

    Obesity is now recognised as a disease associated with significant morbidity and mortality. One of the most common metabolic complications of obesity...

    Moath S. Alsaqaaby, Carel W. le Roux in Diabetology International
    Article 04 April 2023
  3. Gestational weight gain in women with type 1 and type 2 diabetes mellitus is related to both general and diabetes-related clinical characteristics

    Purpose

    To assess predictors of gestational weight gain (GWG), according to the Institute of Medicine (IOM) 2009, in women with type 1 and type 2...

    **nglei **e, Jiaming Liu, ... Rosa Corcoy in Hormones
    Article 16 October 2023
  4. Incretins beyond type 2 diabetes

    Incretin-based therapies, in particular glucagon-like peptide-1 (GLP-1) receptor agonists, have been evaluated in other forms of diabetes, but...

    Chantal Mathieu, Iraj Ahmadzai in Diabetologia
    Article 08 August 2023
  5. Association between ultra-processed food consumption and the incidence of type 2 diabetes: the ELSA-Brasil cohort

    Background

    Ultra-processed food (UPF) consumption increases the risk of type 2 diabetes in various high-income countries, with some variation in the...

    Scheine L. Canhada, Álvaro Vigo, ... Maria Inês Schmidt in Diabetology & Metabolic Syndrome
    Article Open access 15 November 2023
  6. Comparative effects of sodium–glucose cotransporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors on kidney function decline in Japanese individuals with type 2 diabetes

    Background

    Limited direct comparative studies exist in terms of the effects of sodium-glucose cotransporter 2 inhibitors (SGLT2is) and dipeptidyl...

    Naoshi Yoshida, Ko Hanai, Tetsuya Babazono in Clinical and Experimental Nephrology
    Article 13 April 2024
  7. Cost-Effectiveness Analysis of a Prescription Digital Therapeutic in Type 2 Diabetes

    Introduction

    BT-001 (AspyreRx™) prescription digital therapy, a form of personalized cognitive behavioral therapy, has demonstrated clinically...

    Niall J. Davison, Nicole L. Guthrie, ... Mark A. Berman in Advances in Therapy
    Article Open access 03 January 2024
  8. Preventing Type 2 Diabetes after Gestational Diabetes: A Systematic Review Map** Physical Activity Components using the Socio-Ecological Model

    Objectives

    Gestational diabetes commonly occurs during pregnancy and increases lifetime risk of type 2 diabetes following pregnancy. Engaging in...

    Elysa Ioannou, Helen Humphreys, ... Alison Purvis in Maternal and Child Health Journal
    Article Open access 03 June 2024
  9. 2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes

    Background

    Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common liver disease affecting 30% of the world’s population...

    Amélio F. Godoy-Matos, Cynthia Melissa Valério, ... Marcello Casaccia Bertoluci in Diabetology & Metabolic Syndrome
    Article Open access 19 January 2024
  10. Therapeutic patient education and treatment intensification of diabetes and hypertension in subjects with newly diagnosed type 2 diabetes mellitus: a longitudinal study

    Purpose

    The aim of this study is to prospectively evaluate whether individual and group Therapeutic Patient Education (TPE) can reduce the need to...

    Adriana Coppola, Maritza Chuquitaype, ... Carmine Gazzaruso in Endocrine
    Article 24 April 2024
  11. Remission of type 2 diabetes: position statement of the Italian society of diabetes (SID)

    The primary cause of the pandemic scale of type 2 diabetes (T2D) is the excessive and/or abnormal accumulation of adiposity resulting from a chronic...

    Danila Capoccia, Frida Leonetti, ... Valeria Guglielmi in Acta Diabetologica
    Article Open access 28 June 2024
  12. The use of technology in type 2 diabetes and prediabetes: a narrative review

    The increasing incidence of type 2 diabetes, which represents 90% of diabetes cases globally, is a major public health concern. Improved glucose...

    Alexandros L. Liarakos, Jonathan Z. M. Lim, ... Emma G. Wilmot in Diabetologia
    Article Open access 29 June 2024
  13. Surveillance of the liver in type 2 diabetes: important but unfeasible?

    Fatty liver plays a pivotal role in the pathogenesis of the metabolic syndrome and type 2 diabetes. According to an updated classification, any...

    Sami Qadri, Hannele Yki-Järvinen in Diabetologia
    Article Open access 09 February 2024
  14. Diabetes-related distress and quality of life among people with type 2 diabetes at primary care level in Brazil

    Purpose

    Living with diabetes can be challenging, particularly when it comes to dealing with psychological distress and requiring self-care directives....

    Natália Wilcesky Tosini Neves, Jéssica Silva Cunha Breder, ... Maria Helena Melo Lima in Acta Diabetologica
    Article 14 December 2023
  15. Determinants of Course of Type 2 Diabetes in Indian Adolescents

    Objectives

    To identify determinants of the course of Type 2 diabetes in Indian adolescents.

    Methods

    Records of 37 adolescents (24 boys; 29 post...

    Dhvani Raithatha, Proteek Sen, ... Anurag Bajpai in Indian Journal of Pediatrics
    Article 03 June 2024
  16. Effects of prediabetes and type 2 diabetes on cognitive functions

    Introduction

    We aimed to investigate the effect of glycemic impairment in prediabetes on cognitive impairment and the impact of glycemic control on...

    Gülin Alkan Şen, Seher Tanrıkulu, ... Nevin Dinççağ in Endocrine
    Article 15 February 2024
  17. Diagnosis of latent autoimmune diabetes after SARS–Cov2 vaccination in adult patients previously diagnosed with type 2 diabetes mellitus

    Objective

    Acute worsening of glycemic control in diabetic patients and new–onset type I diabetes were reported after severe acute respiratory syndrome...

    Berna İmge Aydoğan, Uğur Ünlütürk, Mustafa Cesur in International Journal of Diabetes in Develo** Countries
    Article 13 October 2023
  18. Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

    The American Diabetes Association and the European Association for the Study of Diabetes convened a panel to update the previous consensus statements...

    Melanie J. Davies, Vanita R. Aroda, ... John B. Buse in Diabetologia
    Article 24 September 2022
  19. Plasma copeptin and markers of arterial disorder in patients with type 2 diabetes, a cross-sectional study

    Objectives

    There is currently limited understanding of the relationship between copeptin, the midregional portion of proadrenomedullin (MRproADM) and...

    Lee Ti Davidson, Jan Engvall, ... Fredrik H. Nyström in Cardiovascular Diabetology
    Article Open access 12 June 2024
  20. Common metabolic features of hypertension and type 2 diabetes

    Hypertension and type 2 diabetes frequently coexist, suggesting that the two diseases have common pathophysiological bases. This review describes the...

    Isao Usui in Hypertension Research
    Article 03 March 2023
Did you find what you were looking for? Share feedback.